Micro Developing Active

Novo Nordisk lança dose mais alta do Wegovy

Pontuação
0,5
Velocidade
▲ 0,0
Artigos
13
Fontes
3

Resumo

Um artigo pertence a esta narrativa se discute o lançamento da Novo Nordisk de uma versão de dose mais alta do seu medicamento para perda de peso Wegovy.

Artigos Relacionados

Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England

Nasdaq · Abr 01, 2026
Mixed

Could This New Approval Be a Turning Point For Novo Nordisk?

Nasdaq · Abr 01, 2026
Mixed

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to …

CNBC · Mar 23, 2026
Mixed

This Hims & Hers Move Could Destroy Competitors

Nasdaq · Mar 21, 2026
Mixed

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

Nasdaq · Mar 20, 2026
Bearish

Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss drugs.

Yahoo Finance · Mar 20, 2026
Mixed

Fontes

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in … CNBC
Could This New Approval Be a Turning Point For Novo … Nasdaq
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In … Nasdaq
Novo Nordisk shares rise after Wegovy recommended by Britain's drug … CNBC
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as … CNBC
India is launching cheap, weight-loss drugs and Novo Nordisk is … CNBC
This Hims & Hers Move Could Destroy Competitors Nasdaq
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too … Nasdaq
Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and … Yahoo Finance

Cronologia

Última atualização Mar 19, 2026